I can't say for sure, but other companies I know do follow the boards, so I would suspect that at least some employees there would be checking in, even if it's not top management that's looking in.
I'm not big on putting down management either, but at times I do question what they're doing. I believe that if you don't trust them to do what's right for the company, you really shouldn't be an investor in the stock.
No investors like dilution, but survival and growth of a company have to be more important than how many shares are outstanding. I'd be perfectly happy with a billion or more shares outstanding if the market cap was double digit billions or more. I believe that's very possible here, provided the company is acquired, and if it is, it should be for double digit billions.
I wasn't around when the company asked some protocol to be taken down, but I wonder why. The protocol should be know by the time the trial is underway, so why the secret. I believe companies often think they're losing their competitive advantage when such things occur, but I suspect the competition knows all that's happening. It's investors who're usually in the dark, as we are today. Any company considering a partnership, or the acquisition of NWBO would be open to learn all about it provided they establish a confidentiality agreement. In short they learn if they're interested in the technology and the status of trials under confidentiality, if nothing results, they don't unlearn what they've seen. Hopefully the company doesn't have such agreements with companies not truly interested in the possibilities, but not every such agreement ends in a partnership or buyout. If two companies can't agree on price, an agreement won't come to fruition, at least not at that moment. Who knows, six months or a year later they might agree on an even higher price based on greater proof than existed when they first looked at the data.
Gary
